The same biologic, ustekinumab 45 mg — one syringe priced from official databases in six places, with its biosimilars where they are listed.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
One pre-filled syringe of Stelara 45 mg/0.5 mL. Each country's own official price; US prices are given per mL and multiplied by 0.5 (our calculation). US dollars at European Central Bank reference rates of October 30, 2026. CMS's fact sheet states Medicare's price per “30-day supply”, which for a drug injected at long intervals is an average, not one syringe — so we use CMS's per-mL price.
STELARA (USTEKINUMAB) · ONE 45 MG SYRINGE
Price by country, November 2026
US figures per mL × 0.5 mL (our calculation). Biosimilars are listed at lower prices in the US and Switzerland.
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (pharmacy cost) | Stelara $29,874.448 per mL; biosimilar Yesintek $2,855.572 per mL (CMS NADAC, Oct 28, 2026) | $14,937 · biosimilar $1,428 | Depends on insurance |
| 🇺🇸 United States (Medicare) | $8,979.65 per mL in 2026, ending Dec 31, 2026 (CMS price file); $4,695 per 30-day supply, 2023 list price $13,836 (CMS fact sheet) | $4,490 | Depends on the Part D plan |
| 🇬🇧 United Kingdom | £2,147.00 per 45 mg syringe (NHS price, since July 1, 2010); biosimilars Pyzchiva, Otulfi, Steqeyma, Uzpruvo, Yesintek £1,932.30, Imuldosa and Wezenla £2,147.00 (hospital-only packs) | $2,877 · biosimilar $2,589 | Usually supplied through the hospital |
| 🇫🇷 France | €1,493.04 per syringe; biosimilars (Pyzchiva, Wezenla, Yesintek, Steqeyma, Otulfi, Uzpruvo, Imuldosa) €1,093.82 (official prices excluding dispensing fee) | $1,668 · biosimilar $1,222 | 35% of the price unless a complementary insurer covers it (65% reimbursed) |
| 🇨🇭 Switzerland | Stelara CHF 1,540.15; biosimilars Imuldosa, Yesintek and Ustekinumab Spirig HC CHF 1,252.65 (public prices) | $1,871 · biosimilar $1,522 | 10% share after the annual deductible |
| 🇦🇹 Austria | Stelara €783.15 per 45 mg syringe; biosimilar Steqeyma €646.00 (social-insurance prices excl. VAT) | $875 · biosimilar $722 | €7.55 prescription fee per pack; only for the listed indications |
| 🇳🇱 Netherlands | €1,593.96 per 45 mg syringe (average pharmacy price) | $1,781 | Reimbursed under conditions; counts toward the annual deductible |
| 🇩🇪 Germany | Reference-price group for ustekinumab created on Sept 17, 2026; ceiling amount not yet set (not on the list of Oct 15, 2026) | — | €10 co-payment per pack (10%, max. €10) |
We compare prices; we do not recommend where to buy medicine. Whether to start, stop or switch a biologic — including to a biosimilar — is a decision for your dermatologist or gastroenterologist.
US pharmacies paid about $14,937 for one Stelara 45 mg syringe in late October 2026 (NADAC). Medicare's negotiated price works out at about $4,490 per syringe ($8,979.65 per mL, CMS price file). The biosimilar Yesintek costs pharmacies about $1,428 for the same dose. CMS's price file ends Stelara's negotiated price on December 31, 2026 and marks the drug as deselected.
France lists one 45 mg syringe at €1,493.04, the Netherlands at €1,593.96 and Switzerland at CHF 1,540.15; the NHS list price is £2,147.00 for a hospital-only pack. Switzerland also lists three biosimilars at CHF 1,252.65.
On September 17, 2026 the Federal Joint Committee added the group “Ustekinumab, Gruppe 1” to the medicines directive; the Federal Ministry of Health did not object on October 14, 2026. The statutory ceiling (Festbetrag) itself is set later by the statutory insurers and is not on the list of October 15, 2026. Until then we show no German price; insured patients pay a 10% co-payment, capped at €10 per pack (€15 from 2027).
US pharmacies pay about $14,937 for one 45 mg syringe (CMS NADAC, October 28, 2026). Medicare's negotiated 2026 price is about $4,490 per syringe. Official prices elsewhere: €1,493.04 in France, €1,593.96 in the Netherlands, CHF 1,540.15 in Switzerland and £2,147.00 in the UK — roughly $1,668 to $2,877 at ECB rates.
Yes. In the US the national pharmacy-price survey lists Yesintek 45 mg at $2,855.572 per mL — about $1,428 per syringe — and further biosimilars at 90 mg. Switzerland lists Imuldosa, Yesintek and Ustekinumab Spirig HC at CHF 1,252.65 per 45 mg syringe.
No, according to CMS's price file of November 2, 2026: Stelara's negotiated price runs from January 1 to December 31, 2026 and the drug is marked as deselected.
CMS's fact sheet gives the negotiated price per “30-day supply”, an average based on how the drug is dispensed. Its price file gives the price per mL: $8,979.65, or about $4,490 for a 0.5 mL syringe (our calculation).
No statutory price ceiling has been set yet. The Federal Joint Committee created a reference-price group for ustekinumab on September 17, 2026, and the ministry did not object on October 14, 2026; the amount is not on the list of October 15, 2026. Insured patients pay a 10% co-payment, capped at €10 per pack.
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; conversions and per-30-tablet figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
